BHI up +11.72% percent Today $BHI High is at 66.89 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 10:38 AM

BHI up +11.72% percent Today $BHI High is at 66.89 and the Low 65.12 with current volume of 24,624,134.

Recent News posted below.

Baker Hughes Inc BHI other info.
http://investorshangout.com/Baker-Hughes-Inc-BHI-50288/

BHI Baker Hughes Inc Recent Headline News

Challenge the Buyout: Ademi & O'Reilly, LLP Investigates Whether Baker Hughes Incorporated Has Obtained a Fair Price in Its Sale to Halliburton Company
GlobeNewswire - 7 mins ago
We are investigating the Board of Directors of Baker Hughes for possible breaches of fiduciary duty and other violations of state law in connection with the sale of Baker Hughes to Halliburton.
BHI: 66.95 (+7.06)

BAKER HUGHES INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - 11 mins ago
Rigrodsky & Long, P.A.:
HAL: 50.90 (-4.18), BHI: 66.95 (+7.06)

Jim Cramer: Going Short? Be Quick or Be Dead in This Market
at The Street - 30 mins ago
Even the best of short ideas can kill you in this market.
OIH: 43.70 (-0.37), ESV: 38.54 (-0.24), WFT: 16.32 (-0.32), HAL: 50.90 (-4.18), HP: 77.56 (-1.45), SLB: 95.76 (+0.44), STO: 21.81 (-0.29), BHI: 66.95 (+7.06), APC: 89.28 (-0.91)

Stock Market Today: U.S. Stocks Slip After Japan's Recession Surprise
at The Street - 49 mins ago
News that Japan fell into recession again in the third quarter causes waves on global markets early Monday morning.
AGN: 213.50 (+14.85), ACT: 254.60 (+10.83), HAL: 50.89 (-4.19), TSN: 42.20 (+1.54), JD: 25.88 (-1.13), BHI: 66.94 (+7.05), BABA: 114.83 (-0.27)

Halliburton Agrees to Buy Baker Hughes in $34.6 Billion Deal
at The Street - 58 mins ago
Halliburton reaches an agreement to buy rival oilfield services company Baker Hughes in a deal valued at $34.6 billion.
HAL: 50.90 (-4.18), BHI: 66.94 (+7.05)

China Telecom, Olympic Steel, Halliburton, Baker Hughes and Schlumberger highlighted as Zacks Bull and Bear of the Day
PR Newswire - 1 hr 7 mins ago
Zacks Equity Research highlights China Telecom (NYSE:CHA-Free Report) as the Bull of the Day and Olympic Steel (Nasdaq:ZEUS-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onHalliburton Co. (NYSE:HAL-Free Report), Baker Hughes Inc. (NYSE:BHI-Free Report) and Schlumberger Ltd. (NYSE:SLB-Free Report).
ZEUS: 18.10 (-0.10), SLB: 95.76 (+0.44), BHI: 66.94 (+7.05)

Halliburton Clinches Baker Hughes Buy For $34.6 Bil
at Investor's Business Daily - 1 hr 12 mins ago
Halliburton (HAL) agreed to buy Baker Hughes (BHI) for $34.6 billion, avoiding a hostile takeover, as the industry faces declining oil prices. Halliburton's cash and stock deal is valued at $78.62 per share. Baker Hughes shareholders will own 36% of...
HAL: 50.92 (-4.16), SLB: 95.76 (+0.44), BHI: 66.95 (+7.06)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - 1 hr 22 mins ago

CADC: 5.54 (+1.28), INO: 10.02 (-0.98), CLDX: 18.37 (+4.21), HAL: 50.91 (-4.17), ROX: 1.77 (-0.21), SNSS: 1.79 (+0.12), DNR: 9.86 (-1.34), DWA: 22.36 (-3.66), GSAT: 2.81 (-0.16), CMGE: 26.29 (+0.69), FOLD: 6.60 (+0.91), BHI: 66.96 (+7.07)

Stock Futures Set For Weak Open; Halliburton, Baker Hughes Merge
at Investor's Business Daily - 1 hr 25 mins ago
Stock futures pointed modestly lower ahead of Monday's open as merger news stirred some of the most notable premarket stock moves. Dow futures sifted 27.7 points below fair market value. Nasdaq 100 futures were 9.1 points lower, and S&P 500 futures...
AGN: 213.50 (+14.85), HAS: 56.00 (+1.98), VRX: 135.52 (+1.31), ACT: 254.60 (+10.83), HAL: 50.88 (-4.20), DIS: 90.63 (-0.17), DWA: 22.36 (-3.66), BHI: 66.99 (+7.10)

Halliburton buying Baker Hughes in $34.6B deal
By JONATHAN FAHEY - AP - 1 hr 44 mins ago
NEW YORK (AP) — In a deal that shows just how quickly falling prices can upend the energy industry, Halliburton is buying rival oilfield services company Baker Hughes in a cash-and-stock deal worth $34.6 billion.
HAL: 50.91 (-4.17), BHI: 66.99 (+7.10)

Stock Market Today: Japan’s Surprise Recession Weighs on U.S. Stock Futures
at The Street - 1 hr 57 mins ago
U.S. stock futures trade lower on Monday, weighed down by Japan's return into recession.
AGN: 213.50 (+14.85), ACT: 254.60 (+10.83), HAL: 50.90 (-4.18), TSN: 42.20 (+1.54), JD: 25.88 (-1.13), BHI: 66.99 (+7.10), BABA: 114.83 (-0.27)

BAKER HUGHES ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Baker Hughes Incorporated, Inc. to Halliburton Company
Business Wire - 2 hrs 6 mins ago
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of Baker Hughes Incorporated (NYSE: BHI) breached their fiduciary duties in connection with the planned merger of the Company with Halliburton Company. Baker Hughes supplies oilfield services, products, technology, and systems to the oil and natural gas industry worldwide.
BHI: 66.99 (+7.10)

Halliburton and Baker Hughes reach deal
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 5:59AM CST

BHI: 66.97 (+7.08)

Halliburton and Baker Hughes Reach Agreement to Combine in Stock and Cash Transaction Valued at $34.6 Billion
Business Wire - Mon Nov 17, 5:45AM CST
--Transaction Values Baker Hughes at $78.62 per Share as of November 12, 2014
HAL: 50.89 (-4.19), BHI: 66.97 (+7.08)

Cramer's Mad Money - I'm Sorry I Ever Heard Of Globalstar (11/14/14)
SA Editor Miriam Metzinger - Seeking Alpha - Sun Nov 16, 5:05AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday November 14. I'm Sorry I Ever Heard of Globalstar (NYSEMKT: GSAT ) . Other stocks mentioned: Qualcomm (NASDAQ: QCOM ), Skyworks (NASDAQ: SWKS ) One of the...
GPRO: 80.71 (+1.56), VIPS: 23.92 (-0.55), HD: 98.82 (+0.58), SWKS: 61.81 (-0.99), GMCR: 155.00 (+0.73), HAL: 50.90 (-4.18), DECK: 93.28 (+1.49), TSN: 42.19 (+1.53), GSAT: 2.81 (-0.16), WWAV: 36.65 (+0.09), HAIN: 108.95 (+0.68), JACK: 71.40 (-0.35), MHR: 4.59 (-0.24), CBRL: 119.94 (-0.52), LRCX: 78.60 (-1.21), QCOM: 70.65 (-0.20), EOG: 96.55 (-1.61), FL: 55.60 (-0.39), MBLY: 46.53 (-0.90), APC: 89.26 (-0.93), BHI: 66.96 (+7.07), BABA: 114.83 (-0.27), PETM: 72.91 (+0.07), CRM: 63.72 (-0.19)

The One Sector You Must Own Today (Part II)
Joseph L. Shaefer - Seeking Alpha - Sat Nov 15, 9:47AM CST
For Part I, go here . Supply and Demand in the Oil and Gas Sector I'm not saying today's headline on Marketwatch is the new reverse indicator a la the cover of Business Week, but I am delighted to see the banner headline titled "Oil,...
GE: 26.58 (+0.12), OII: 69.00 (-0.04), NBR: 16.00 (-0.59), HAL: 50.90 (-4.18), COP: 70.72 (-0.69), HP: 77.56 (-1.45), SDRL: 20.52 (-0.26), PTEN: 20.69 (-0.64), SLB: 95.76 (+0.44), PACD: 6.63 (-0.11), RIG: 25.65 (-0.40), ESV: 38.54 (-0.24), FLR: 63.77 (-0.93), FTI: 54.13 (-0.18), ATW: 35.38 (-0.10), RDC: 23.25 (-0.50), BHI: 66.96 (+7.07), NE: 20.36 (-0.45)

Halliburton Strikes First Blow In Oil Industry Downsizing With BHI Bid
Dana Blankenhorn - at Seeking Alpha - Sat Nov 15, 9:04AM CST

HAL: 50.91 (-4.17), WFT: 16.32 (-0.32), BHI: 66.96 (+7.07)

Baker Hughes: Halliburton aims to replace board
By The Associated Press - AP - Fri Nov 14, 10:10PM CST
HOUSTON (AP) — Oilfield-services company Baker Hughes Inc. said Friday that rival Halliburton Co. plans to nominate candidates to replace the entire board of directors of Baker Hughes after negotiations about a possible acquisition stalled.
HAL: 50.90 (-4.18), BHI: 66.96 (+7.07)

Halliburton goes hostile on Baker Hughes
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 8:26PM CST

HAL: 50.90 (-4.18), BHI: 66.96 (+7.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...